Viewing Study NCT03575260


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-03-06 @ 1:13 PM
Study NCT ID: NCT03575260
Status: COMPLETED
Last Update Posted: 2019-07-30
First Post: 2018-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 500mg Fulvestrant Versus Exemestane in MBC
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fulvestrant View
None Exemestane View